BioTel Research Blog
BTR_Cardiac_Testing_headerBG.jpg

BioTel Research Blog

Archived Webinar: Key Takeaways from the New CSRC/FDA Meeting on Cardiac Safety and Cardiovascular Safety Issues in Oncology Drug Development.

Posted by Fariba Ahdoot on October 11, 2017
On October 24-25, 2017 scientific experts gathered at the Cardiac Safety Research Consortium (CSRC)/FDA Annual Meeting to discuss cardiac risk management and safety assessment in oncology drug development. BioTelemetry Research’s Chief Medical Officer, Polina Voloshko, MD, and Vice President and Medical Director, Daniel Goodman, MD, attended the annual meeting and presented a complimentary ...
Read More

Topics: Cardiac Safety

Driving Data to Help Patients

Posted by Patricia Veasey on July 11, 2017
In this technical age, data drives our daily activities. How much data can my phone store? What kind of computer can handle all of my tasks? How many movies can I leave on my DVR before I can no longer record? How many viewers tuned in to the season finale of The Walking Dead? Answering any of these questions requires working with data: examining it, and interpreting the results into meaningful ...
Read More

Topics: Cardiac Safety

Call to Action Pharma and Medical Device developers: Centralize and Standardize Your ECGs!

Posted by Bob Goodman on December 05, 2016
Within the pharmaceutical research industry, we broadly agree that centralization and standardization of biological samples improves clinical trial accuracy and efficiency, but for some reason we don’t always recognize that those same benefits apply to ECG centralization. After discussing this topic with experts across the industry I’m struggling to find a good reason why ECG acquisition, ...
Read More

Topics: Cardiac Safety

Cardiovascular Effects within Cancer Therapies and Drug Development

Posted by Fariba Ahdoot on November 29, 2016
Cancer survivors in the United States, totaling nearly 15 million people, continue to face challenges following remission. These challenges include the risk of cancer recurrence and cardiovascular comorbidities that can manifest during and after cancer therapy. A recent article published by the New England Journal of Medicine, outlines the impact of cancer therapies on cardiovascular function and ...
Read More

Topics: Cardiac Safety

BioTel Research, One Preserve Parkway, Suite #600, Rockville, MD 20852